Background: Pulmonary rehabilitation is successful in improving exercise capacity and quality of life in patients with chronic obstructive pulmonary disease (COPD). However, training effects diminish over time. Objectives: We evaluated the effects of simple, daily, structured, self-monitored, home-based exercise training for patients with moderate COPD after a 3-week outpatient rehabilitation. Methods: We conducted a randomized, controlled, observer-blind trial. Twenty patients were recruited. Ten patients performed home-based exercise training (mean age 67 years, 95% confidence interval [CI] 63–72; FEV1 58.6%, 95% CI 53.8–63.4), and 10 patients served as controls (mean age 72 years, 95% CI 69–77; FEV1 62.5%, 95% CI 57.7–67.3). At baseline, and after 3 and 6 months, we assessed exercise capacity (6-min walk test, 6MWT, primary endpoint), health-related quality of life (Chronic Respiratory Questionnaire, CRQ) and lung function. An intention-to-treat analysis was performed using two-way ANOVA models for comparison of time trends between random groups. Results: The training group had better results than the control group in 6MWT (p = 0.033), in CRQ total (p = 0.027), CRQ dyspnea (p = 0.014) and CRQ fatigue (p = 0.016). Improvement in FEV1 was also better in the intervention group than in the control group (p = 0.007). Conclusions: We demonstrated that training effects obtained from an outpatient rehabilitation program can be maintained by home-based exercise training in patients with moderate COPD.

Keywords:
Chronic obstructive pulmonary disease, Exercise capacity, Physical exercise, Pulmonary rehabilitation
1.
Celli BR, MacNee W, ATS/ERS Task Force: Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2006;23:932–946.
2.
Sin DD, Man SFP: Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax 2006;61:1–3.
3.
van Eeden SF, Sin DD: Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008;75:224–238.
4.
Lacasse Y, Goldstein R, Lasserson TJ, Martin S: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, CD003793.
5.
GOLD – Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease 2007: Executive summary. www.goldcopd.com. Accessed March 21, 2008.
6.
Salmann GF, Mosier MC, Beasley, Calkins DR: Rehabilitation for patients with chronic obstructive pulmonary disease: meta-analysis of randomized controlled trials. J Gen Intern Med 2003;18:213–221.
7.
Singh SJ, Smith DL, Hyland ME, Morgan MDL: A short outpatient pulmonary rehabilitation programme: immediate and longer term effects on exercise performance and quality of life. Respir Med 1998;92:1146–1154.
8.
Troosters T, Gosselink R, Decramer M: Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 2000;109:207–212.
9.
Ries AL, Kaplan RM, Limberg TM, Prewitt L: Effects of pulmonary rehabilitation on physiologic and psychological outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995;122:823–832.
10.
Gosselink R: Respiratory rehabilitation: improvement of short- and long-term outcome. Eur Respir J 2002;20:4–5.
11.
Nici L: Can we make it last? Maintaining benefits achieved with pulmonary rehabilitation. Lung 2007;185:241–242.
12.
Ries AL, Kaplan AM, Myers R, Prewitt LM: Maintenance after pulmonary rehabilitation in chronic lung disease. Am J Respir Crit Care Med 2003;167:880–888.
13.
Wijkstra PJ, TenVergert EM, van Altena R, Otten V, Kraan J, Postma DS, Koëter GH: Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. Thorax 1995;50:824–828.
14.
Brooks D, Krip B, Mangovski-Alzamora S, Goldstein RS: The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease. Eur Respir J 2002;20:20–29.
15.
Behnke M, Taube C, Kirsten D, Lehnigk B, Jörres RA, Magnussen H: Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir Med 2000;94:1184–1191.
16.
Boueri FM, Bucher-Bartelson BL, Glenn KA, Make BJ: Quality of life measured with a generic instrument (Short Form-36) improves following pulmonary rehabilitation in patients with COPD. Chest 2001;119:77–84.
17.
von Leupoldt A, Hahn E, Taube K, Schubert-Heukeshoven S, Magnussen H, Dahme B: Effects of 3-week outpatient pulmonary rehabilitation on exercise capacity, dyspnea, and quality of life in COPD. Lung, E-pub ahead of print.
18.
Miyahara N, Eda R, Takeyama H, Kunichika N, Moriyama M, Aoe K, Kohara H, Chikamori K, Maeda T, Harada M: Effects of short-term pulmonary rehabilitation on exercise capacity and quality of life in patients with chronic obstructive pulmonary disease. Acta Med Okayama 2000;54:179–184.
19.
Nici L, Donner C, Wouters E, et al: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390–1413.
20.
Ries AL, Bauldorff GS, Carlin BW, et al: Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007;131(suppl 5):4S–42S.
21.
Enright PL: The six-minute walk test. Respir Care 2003;48:783–785.
22.
American Thoracic Society: ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111–117.
23.
Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH: Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997;155:1278–1282.
24.
Puhan MA, Behnke M, Frey M, Grueter T, Brandli O, Lichtenschopf A, Guyatt GH, Schunemann HJ: Self-administration and interviewer-administration of the German Chronic Respiratory Questionnaire: instrument development and assessment of validity and reliability in two randomised studies. Health Qual Life Outcomes 2004;2:1.
25.
Puhan MA, Behnke M, Laschke M, Lichtenschopf A, Brändli O, Guyatt GH, Schünemann HJ: Self-administration and standardisation of the chronic respiratory questionnaire: a randomised trial in three German-speaking countries. Respir Med 2004;98:342–350.
26.
Redelmeier DA, Guyatt GH, Goldstein RS: Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996;49:1215–1219.
27.
Armitage P, Berry G, Matthews JNS: Statistical Methods in Medical Research, ed 4. Oxford, Blackwell Science, 2002, pp 607–609.
28.
Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM: Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007;175:458–463.
29.
Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR: The 6-min walk distance: change over time and value as predictor of survival in severe COPD. Eur Respir J 2004;23:28–33.
30.
Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T: Analysis of factors related to mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;67:544–549.
31.
Garcia-Aymerich, Lange P, Benet M, Schnohr P, Anto JM: Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006;61:772–778.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.